Overview * Inspire Medical ( INSP ) Q3 revenue rises 10% yr/yr, beating analyst expectations * Company completed $50 mln share repurchase, indicating confidence in future growth * Transition to Inspire V system progressing well with positive clinician feedback Outlook * Company reaffirms full-year revenue guidance of $900 mln to $910 mln * Company raises full-year diluted net income per...

Overview * Sanmina ( SANM ) Q4 revenue grows to $2.1 bln, beating analyst expectations * Non-GAAP diluted EPS for Q4 shows significant growth * Company repurchased 1.44 mln shares for $114 mln in FY25 Outlook * Sanmina ( SANM ) expects Q1 revenue between $2.9 bln and $3.2 bln * Company anticipates Q1 non-GAAP EPS between $1.95 and $2.25...

Overview * SBA Communications ( SBAC ) Q3 revenue beats analyst expectations * Net income for Q3 declines compared to last year * Company repurchased 958 thousand shares during and after Q3 Outlook * Company updates 2025 site leasing revenue outlook to $2,568.0 mln-$2,578.0 mln * Company revises target leverage range to 6.0x-7.0x net debt to LQA Adjusted EBITDA *...

Overview * Biodesix Q3 2025 revenue grows 20% yr/yr, beating analyst expectations * Company raises FY2025 revenue guidance to $84-86 mln * Gross profit margin improves by 400 basis points yr/yr Outlook * Biodesix ( BDSX ) raises FY2025 revenue guidance to $84-86 mln * Company expects Adjusted EBITDA positivity in Q4 2025 * Biodesix ( BDSX ) sees sustainable...